For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| Botox® | Botox® and Nd:YAG Laser: 1440 nm Laser | 0 | None | 0 | 8 | 8 | 8 | View |
| miraDry® | miraDry® and Nd:YAG 1440 nm Laser | 0 | None | 0 | 9 | 9 | 9 | View |
| Nd: YAG Laser | Nd: YAG laser: 1440nm | 0 | None | 0 | 17 | 17 | 17 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Numbness | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | None | View |
| Pain | SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| Redness | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | None | View |
| Swelling | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | None | View |
| Bruising | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | None | View |
| Itching | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | None | View |
| Nodule | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | None | View |
| Hardness | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | None | View |